Literature DB >> 655981

The use of electrocardiography in the diagnosis of poor racing performance in the horse.

R J Rose, P E Davis.   

Abstract

Electrocardiograms were reocrded from 153 racehorses and 10 Olympic three-day-event horses. The horses were then grouped into those presented for routine examination, those in which there was a complaint of poor performance, those going to the Montreal Olympics, and those with upper respiratory tract abnormalities. When the ECGs of the four groups were compared on the basis of detection of abnormality, it was found that 93.2% of the poor performance group showed abnormalities of various types. The routine examination group showed 21.1% of horses with abnormal ECGs, and over half of these have been followed to the point where it can be said they raced unsuccessfully. In particular, this applied to those horses with T wave abnormalities in 4 or more leads, and to those with intraatrial block. There were significant T wave changes in 50% of the Olympic horses, and 43.7% of horses with laryngeal hemiplegia showed abnormality. While it can be concluded that T wave changes are highly significant findings in an ECG, it is also true that modification of the training programme is a way of helping trainers to get the best out of horses which might otherwise have a serious limitation of their performance potential.

Entities:  

Mesh:

Year:  1978        PMID: 655981     DOI: 10.1111/j.1751-0813.1978.tb00341.x

Source DB:  PubMed          Journal:  Aust Vet J        ISSN: 0005-0423            Impact factor:   1.281


  2 in total

1.  The ratio of cardiopulmonary blood volume to stroke volume as an index of cardiac function in horses.

Authors:  M N van Aarde; A Littlejohn; J J Van der Walt
Journal:  Vet Res Commun       Date:  1984-11       Impact factor: 2.459

2.  Relationship of plasma lactate production to cortisol release following completion of different types of sporting events in horses.

Authors:  D Desmecht; A Linden; H Amory; T Art; P Lekeux
Journal:  Vet Res Commun       Date:  1996       Impact factor: 2.459

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.